Stock INDEX INDEX PHARMACEUTICALS HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

News InDex Pharmaceuticals Holding AB

Equities

INDEX

SE0008966295

Market Closed - Nasdaq Stockholm
Other stock markets
 16:29:54 02/05/2024 BST 		5-day change 1st Jan Change
0.382 SEK -3.05% Intraday chart for InDex Pharmaceuticals Holding AB +9.77% +49.22%
04-26 InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-05 Index Pharmaceuticals Holding AB Announces Board Resignations CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
InDex Pharmaceuticals Holding AB (publ) interim report January - March 2024
AQ
InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
InDex Pharmaceuticals brings forward the publication of the interim report for Q1 2024
AQ
InDex Pharmaceuticals provides a company update
AQ
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2023
AQ
Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)
AQ
Index Pharmaceuticals Holding AB Announces Board Resignations
CI
InDex Pharmaceuticals CEO, CFO to Step Down as Operations Cease
MT
CEO and CFO both to leave InDex Pharmaceuticals
AQ
Index Pharmaceuticals Holding AB Announces Resignation of Johan Giléus as Deputy CEO
CI
InDex Pharmaceuticals Holding AB Announces Resignation of Jenny Sundqvist as CEO, Effective September 26, 2024
CI
InDex Pharmaceuticals Holding AB Announce Resignation of Johan Giléus as CFO, Effective September 26, 2024
CI
InDex Pharmaceuticals Launches Strategic Review Amid Decision to Stop Cobitolimod Development
MT
InDex Pharmaceuticals provides an update on company's future
AQ
InDex Pharmaceuticals discontinues the development of cobitolimod
AQ
InDex Pharmaceuticals Holding AB Discontinues the Development of Cobitolimod
CI
InDex Pharmaceuticals Holding AB (publ) year-end report 2023
AQ
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
InDex Pharmaceuticals announces expected cash balance per March 31, 2024
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INDEX Stock
  4. News InDex Pharmaceuticals Holding AB